Fig. 1From: Real-world treatment patterns, healthcare resource use and clinical outcomes of patients receiving second line therapy for advanced or metastatic gastric cancerSankey Diagram of most common therapies prescribed in 1 L, 2 L and 3 L treatmentBack to article page